Primary: How to Value a Company: DCF, Comps, LBO & Other Valuation Methods

Valuation methods are the backbone of deal-making, capital allocation, and corporate strategy. Whether you’re pricing a startup, assessing an acquisition target, or preparing financial statements, choosing the right valuation approach and documenting assumptions clearly separates credible analysis from guesswork.

Core valuation approaches
– Discounted Cash Flow (DCF): Projects a company’s free cash flows and discounts them using a rate that reflects risk (commonly WACC). Terminal value usually uses a perpetuity growth model or an exit multiple. DCF is powerful for companies with predictable cash generation.
– Comparable Company Analysis (Comps): Values a business by applying market multiples (EV/EBITDA, P/E, EV/Sales) from similar public companies. Useful for a market-relative view and quick sanity checks.
– Precedent Transactions: Uses multiples from actual M&A deals involving comparable targets.

Reflects control premiums and deal dynamics, often showing higher valuations than public comps.
– Asset-Based Valuation: Values net assets at market or liquidation values. Common in asset-heavy industries or distressed scenarios.
– Real Options and Scenario-Based Methods: Prices managerial flexibility—expansion, abandonment, or staging—common in natural resources, biotech, and tech ventures.
– Leveraged Buyout (LBO) Analysis: A buyer-focused model that tests what price an acquirer can pay to achieve target IRRs, considering debt capacity and exit assumptions.

Practical considerations for robust valuations
– Normalize financials: Strip out one-time items, owner compensation distortions, and cyclical anomalies to get repeatable earnings or cash flows.
– Choose the right multiples: Use industry-appropriate metrics. Early-stage firms may be valued on revenue multiples; mature firms often use EBITDA or free cash flow metrics.
– Adjust for capital structure: Distinguish enterprise value (EV) from equity value; apply appropriate capital structure adjustments for leverage differences across comparables.
– Account for control and marketability: Precedent transactions usually incorporate control premiums.

Private-company valuations should consider discounts for lack of marketability or minority stakes.
– Terminal value sensitivity: Terminal value often dominates a DCF. Present results using both perpetuity growth and exit multiple approaches and show sensitivities for growth and discount rates.
– Use scenario and sensitivity analysis: Present a valuation range based on conservative, base, and optimistic cases. Sensitivity tables around WACC, growth, and margins clarify which assumptions matter most.
– Document assumptions and sources: Credible valuations cite market data for multiples, industry reports, and management projections. Transparency is essential for stakeholder buy-in.

Industry and stage matter
Different industries and company stages call for different approaches.

Asset-heavy firms and distressed businesses lean toward asset-based methods; stable cash generators suit DCF; high-growth or early-stage companies often rely on comparable multiples, precedent deals, or real-option thinking.

Regulatory environments, market liquidity, and technological disruption all influence method choice and the size of applied discounts or premiums.

Valuation is both art and science. Rigorous models, disciplined normalization, and careful selection of comparables provide the scientific backbone, while judgment about growth prospects, competitive position, and synergies supplies the art. Presenting a well-explained range of values, rather than a single point estimate, gives decision-makers the context needed to act with confidence.